Articles From: 2014/11/18 - Erie Insurance offers unique, new ridesharing coverage for drivers to - Allegiant Makes It Easy to Get to the Big Easy With New Nonstop Flights as Low as $45 One Way


2014/11/18
New car insurance fills gaps and covers drivers before, during and after trips ERIE, Pa.
Sign-up for 2014/11/18 - Erie Insurance offers unique, new ridesharing coverage for drivers investment picks
Jake Elguicze, Treasurer and Vice President of Investor Relations, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 26 th Annual Piper Jaffray Healthcare Conference at The New York Palace Hotel, in New York City, on Tuesday, December 2, 2014 at 8:30 a.m. (ET). A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor section of the Teleflex website at www.teleflex.com .
Sign-up for - Teleflex to Present at the 26th Annual Piper Jaffray Healthcare Conference investment picks
MCLEAN, Va.
Sign-up for - CYREN Reports Third Quarter 2014 Results investment picks
2014/11/18
By Shawn Langlois, MarketWatch Critical intelligence before the U.S. market opens The deep chill in this market that began last week is now reaching historical proportions.
Sign-up for 2014/11/18 - Bone-chilling temps put the U.S. and the stock market in a deep freeze investment picks
2014/11/18
http://media.marketwire.com/attachments/201211/103635_zyto-logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1160103&ProfileId=051205&sourceType=1 LINDON, UTAH --
Sign-up for 2014/11/18 - ZYTO Is Named as a Utah Top Workplace investment picks
Clovis Oncology (NASDAQ:CLVS) announced today updated findings from its ongoing Phase 2 clinical study of rociletinib (CO-1686), the Company’s novel, oral, targeted covalent (irreversible) mutant-selective inhibitor of the epidermal growth factor receptor (EGFR) for the treatment of NSCLC in patients with initial activating EGFR mutations as well as the primary resistance mutation T790M.
Sign-up for - Interim Data from Rociletinib (CO-1686) Phase 1/2 Study Shows Compelling and Durable Clinical Activity and Progression-free Survival (PFS) in Patients with EGFR-Mutant Non-small Cell Lung Cancer (NSCLC) investment picks
2014/11/18
By Jennifer Booton, MarketWatch Snapchat and Square hope to challenge Paypal's Venmo NEW YORK (MarketWatch) -- When Snapchat unveiled a peer-to-peer payments service on Monday, your first thought might have been: Why would I want to send money through an app best known for being a conduit for sexually explicit messages?
Sign-up for 2014/11/18 - UPDATE: Snapcash could win over millennials investment picks
2014/11/18
- Fourth Quarter and Fiscal Year 2014 Net Revenue Exceed Guidance, Reaching $35.3 Million and $97.2 Million, Respectively - - 4QFY14 Net Income Up 47.5% Year-Over-Year to $13.4 Million - - FY14 Net Income Up 72.6% Year-Over-Year to $23.4 Million - - Company Issues FY15 Net Revenue Growth Outlook of 27% to 32% - - Declares Annual Cash Dividend of $0.20 per Ordinary Share or $0.80 per ADS - BEIJING , Nov.
Sign-up for 2014/11/18 - China Distance Education Holdings Limited Reports Financial Results for the Fourth Quarter and Full Year 2014 investment picks
CLEVELAND , Nov.
Sign-up for - PolyOne To Present at the Citi 2014 Basic Materials Conference investment picks
2014/11/18
Macy’s, Inc. (NYSE:M) today announced that its wholly owned subsidiary, Macy’s Retail Holdings, Inc., will redeem for cash the entire $406.62 million aggregate principal amount outstanding of its 7.875% senior notes due 2015 (CUSIP 55616XAE7) on December 15, 2014.
Sign-up for 2014/11/18 - Macy’s, Inc. to Redeem 7.875% Senior Notes Due 2015 investment picks
Intevac, Inc. (Nasdaq:IVAC) announced today that the company will participate in the 2014 Interservice/Industry Training Simulation and Education Conference (I/ITSEC). Intevac Photonics will showcase their innovative high-resolution near-eye display systems.
Sign-up for - Intevac to Participate in 2014 Interservice/Industry Training Simulation and Education Conference investment picks
Cloud Peak Energy Inc. (NYSE: CLD) (“CPE Inc.”) announced that it has commenced a registered underwritten public offering of its Series A mandatory convertible preferred stock consisting of 100,000 shares with a liquidation preference of $1,000 per share.
Sign-up for - Cloud Peak Energy Inc. Announces Public Offering of $100 Million of Mandatory Convertible Preferred Stock investment picks
Genzyme , a Sanofi company, and Isis Pharmaceuticals Inc. (NASDAQ: ISIS), today announced that new two-year data from a phase 3 long-term extension study of KYNAMRO ® (mipomersen sodium) injection was presented at a scientific session at the annual American Heart Association meeting in Chicago, IL.
Sign-up for - Genzyme and Isis Present KYNAMRO® Clinical Data at the American Heart Association investment picks
2014/11/18
http://media.marketwire.com/attachments/200704/331662_AllstarUSA.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159949&ProfileId=051205&sourceType=1 BOSTON, MA --
Sign-up for 2014/11/18 - Liberty All-Star(R) Equity Fund October 2014 Update investment picks
By Ruth Mantell, MarketWatch WASHINGTON (MarketWatch) -- The financial chief of home improvement behemoth Home Depot on Tuesday said she is "very encouraged" by recent progress by regulators on mortgage availability.
Sign-up for - UPDATE: Home Depot CFO 'very encouraged' by regulators' mortgage-reform work investment picks
2014/11/18
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0979754001&sourceType=1 http://media3.marketwire.com/logos/20140918-DGR200.jpg TORONTO, ONTARIO --
Sign-up for 2014/11/18 - Dream Global REIT November 2014 Monthly Distribution investment picks
Citizens Financial Group, Inc. (NYSE: CFG) today named Marc Paulhus, Head of Asset Finance for Citizens Commercial Banking, as Citizens Bank Rhode Island President.
Sign-up for - Marc Paulhus Appointed Citizens Bank Rhode Island President investment picks
2014/11/18
By Noemie Bisserbe PARIS--French prosecutors have launched a preliminary insider-trading probe targeting several senior managers at BNP Paribas SA, a person with direct knowledge of the matter said Tuesday.
Sign-up for 2014/11/18 - Senior BNP Paribas managers target of French preliminary insider-trading probe investment picks
PLEASANT GROVE, Utah, Nov.
Sign-up for - ForeverGreen Worldwide Corporation to Continue Production and Sale of Azul and FrequenSea investment picks
2014/11/18
By Carla Mozee, MarketWatch Higher prices for computer games help lift U.K. inflation LONDON (MarketWatch) -- U.K. stocks rose Tuesday, with AstraZeneca PLC shares higher on talk about the potential for a new bid for the drug maker.
Sign-up for 2014/11/18 - UPDATE: AstraZeneca advances in London; pound rises as inflation ticks up investment picks
2014/11/18
Former United States Securities and Exchange Commission attorney Willie Briscoe , founder of The Briscoe Law Firm, PLLC , and the securities litigation firm of Powers Taylor LLP announce that a class action lawsuit has been filed against Pacira Pharmaceuticals, Inc. (“Pacira” or “Company”) (NasdaqGS: PCRX) and several officers and directors for acts taken during the period of April 9, 2012 to September 24, 2014 (the “Class Period”). Based upon the allegations in the class action, the firms are investigating additional legal claims against the officers and Board of Directors of Pacira.
Sign-up for 2014/11/18 - Pacira Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors investment picks
Data was presented at the American Heart Association meeting in Chicago on November 17, 2014 regarding the safety and feasibility of Cytori Cell Therapy using Adipose Derived Regenerative Cells (ADRCs™) administered through the coronary artery in patients with acute ST segment elevated myocardial infarction from the ADVANCE clinical trial sponsored by Cytori Therapeutics, Inc. (NASDAQ: CYTX). The ADVANCE clinical trial sought to define the safety, feasibility and efficacy of an intracoronary infusion of ADRCs in patients admitted with an acute ST-elevation myocardial infarction (STEMI) within 24 hours of successful primary percutaneous coronary intervention (PCI). In this randomized, double-blind, placebo-controlled trial (n=23, 2:1 randomization), within 24 hours of successful primary PCI following STEMI, a small volume liposuction was performed for fat harvest and ADRC
Sign-up for - Safety and Feasibility of Cytori Cell Therapy in Acute Myocardial Infarction Presented at 2014 American Heart Association Meeting investment picks
LEVITTOWN, Pa.
Sign-up for - William Penn Bancorp, Inc. Announces First Quarter Earnings investment picks
Tech stocks got off to a strong start Tuesday, with digital-sport camera maker GoPro Inc. (GPRO) among the advancers.
Sign-up for - GoPro, Ambarella shares lead tech advance investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G026679-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/18/11G026679/convertedPNGlogo-210287949.jpg NEW ORLEANS, LA--(Marketwired - November 18, 2014) - Click to Tweet: .@AllegiantTravel announces its arrival at @NO_Airport with fares from $45 and free flights for a year giveaway http://gofly.us/E4HuE FOR DOWNLOADABLE BROADCAST QUALITY VIDEO VISIT: http://gofly.us/qSqyY •Allegiant B-roll footage Allegiant (NASDAQ: ALGT) today announces new non-stop, jet service to New Orleans, the carrier's newest destination.
Sign-up for - Allegiant Makes It Easy to Get to the Big Easy With New Nonstop Flights as Low as $45 One Way investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: 2014/11/18 - Erie Insurance offers unique, new ridesharing coverage for drivers to - Allegiant Makes It Easy to Get to the Big Easy With New Nonstop Flights as Low as $45 One Way
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent